Improving Nutrition and Health Outcomes in Intibuca, Honduras (MANI I)

Malnutrition Clinical Trial

— MANI I  

Official title:

Improving Nutrition and Health Outcomes in Intibuca, Honduras

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01312987
• Other study ID #: MANI I, Shoulder to Shoulder
• Status: Completed
• Phase: N/A
• First received: March 5, 2011
• Last updated: July 31, 2011
• Start date: March 2009
• Est. completion date: April 2010

Study information

• Verified date: July 2011
• Source: Shoulder to Shoulder
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to assess what impact an integrated educational and feeding intervention delivered to infants and children has on growth (weight and height), development (cognitive and gross motor), nutrition (dietary behaviors, food insecurity, and micronutrient status - folate, iron, zinc, vitamin A, vitamin D), and morbidity (respiratory and diarrheal) outcomes. A randomized community trial was used to implement a nutrition intervention program consisting of monthly education sessions, a lipid-based nutrition supplement, and food vouchers for local staples.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: April 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 5 Months to 18 Months

Eligibility

Inclusion Criteria:

• All healthy children between the ages of 5-18 months old and their mothers who are residents of the municipalities of Santa Lucia, Magdalena and San Antonio who do not present any of the medical conditions listed in the exclusion criteria.

• Mothers have understood and signed consent forms to enable their children to participate in the study. They were willing to have their child participate in one or more blood draws, bi-monthly sessions: 1) nutrition classes and food voucher and lipid-based nutritional supplement and 2) height/weight monitoring, dietary intake questionnaire, and health outcome information. As well as the additional data assessments necessary to be considered active participants in the study.

Exclusion Criteria:

• Children with congenital anomalies, mental retardation, severe physical handicap, under-nutrition caused by medical conditions that contribute to under-nutrition such as heart disease, kidney failure, face and throat problems that interfere with swallowing, medical problems interfering with the absorption of food, chronic diseases such as tuberculosis, etc.

• Children with a known allergy to peanuts and eggs will also be excluded from the study, 30% of children with known allergies to nuts also have an allergy to eggs.

• Plans to move or change their place of residence outside of the study region in the next 2 months would make them ineligible.

• Mothers who are younger than 16 years of age will be excluded from the study. Women younger than 16 might not understand the consent process and the importance of following the guidelines established in the research, therefore we chose not to include this group as "eligible" participants.

• Children who are <= -2 standard deviations below the norm for z score for weight for age. These children are severely malnourished and need to be carefully followed under the supervision of a qualified health care provider.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Malnutrition
• Undernutrition

Intervention

Dietary Supplement:
• Lipid-based nutritional supplement
After gradual introduction of the lipid-based nutritional supplement, daily dose per child is as follows: 3 teaspoons 3 x day for children younger than 12 months 4.5 teaspoons 3 x day for children older than 12 months

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Shoulder to Shoulder	The Mathile Institute for the Advancement of Human Nutrition

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in height at 12 months	Participating children were measured by trained staff every month during the 12 month intervention.	Baseline to month 12	No
Primary	Change from baseline in hemoglobin status at 12 months	Hemoglobin status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No
Primary	Change from baseline in serum transferrin status at 12 months	Serum transferritin was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No
Primary	Change from baseline in C-Reactive Protein levels at 12 months	C-Reactive Protein was measured from dried blood spots collected at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No
Primary	Change from baseline in weight at 12 months	Participating children were weighed by trained staff every month during the 12 month intervention.	Baseline to month 12	No
Secondary	Change from baseline in zinc levels at 12 months	Zinc status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No
Secondary	Change from baseline in food insecurity status at 12 months	Assessment teams administered a scored questionnaire at baseline and month 12 of the intervention.	Baseline to month 12	No
Secondary	Change from baseline in dietary intake based on 24-Hour Food Recall at 12 months	Assessment teams administered a 24-Hour Food Recall every month of the intervention.	Baseline to month 12	No
Secondary	Change from baseline in various health outcomes at 12 months	Assessment teams administered a scored questionnaire every month of the intervention.	Baseline to month 12	No
Secondary	Change from baseline in acceptability of nutrition supplement at 12 months	Assessment teams administered a scored questionnaire at baseline, month 6, and month 12 of the intervention	Baseline to month 12	No
Secondary	Change from baseline in folate status at 12 months	Folate status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No
Secondary	Change from baseline in vitamin B12 status at 12 months	Vitamin B12 was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.	Baseline to month 12	No